Erschienen in:
01.03.2010 | Breast Oncology
Author Reply: Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery
verfasst von:
Amanda Arrington, MD, Todd Tuttle, MD, MS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 3/2010
Einloggen, um Zugang zu erhalten
Excerpt
We appreciate the comments from Dr. Zografos and Dr. Roukos regarding our research on the use of contralateral prophylactic mastectomy (CPM). We previously reported that the CPM rate in the United States increased by more than 150% from 1998 to 2003 among patients with unilateral invasive breast cancer.
1 In this study, these trends continued to the end of the study period with no plateau effect. We suspect that CPM rates have increased since 2003, but have not conducted such research. …